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Background
Congenital bicuspid aortic valve (BAV) – one of the
most frequent cardiovascular lesions, with prevalence up
to 2.4%. About a half of them need the surgical treat-
ment throughout life.
Methods
1217 patients with BAV were treated in the Institute
during 2003−2012. There were 902 (74.1%) males.
Patients age ranged from 3 days to 76 years, mean 50.2
± 9,8 years. Aneurysm of ascending aorta took place in
380 (31.2%) pts, 39 (10,3%) of them admitted with dis-
section. We use: balloon valvuloplasty in 82 (8.1%)
patients. Different operative interventions were fulfilled
to the rest :1135 (93,3%) pts: open aortic valvotomy −
64 (5,3%), aortic valve replacement (AVR) – 691 (56.8%),
AVR with ascending aorta banding – in 83 (6,8%),
Robicsek operation – 121 (10.0%), Bentall’s operation –
162 (13.3%), Wheat’s operation – 9 (0.7%), supracoronary
aortic grafting with AV resurpension – 3 (0.2%), David’s
operation – 2 (0.2%); 51 (4.2%) patients with BAV treated
of coarctation of the aorta earlier.
Results
Total 30-day mortality composed 2.3% (26 pts). Death
causes: acute heart failure – in 13 (1,1%); respiratory
insufficiency – in 4 (0.3%), bleeding – in 2 (0.2%), multi-
organ failure – in 4 (0,3%), cerebral injury – in 3 (0.2%).
Remote results were studied in 1110 (93.7%) discharged
patients in term 6 months – 9 years, mean 3,6±1,2. In
mostly – 84.4% and 10.9% it was good and satisfactory.
Unsatisfactory in 23 (2.0%), died in remote terms 27
(2,4%) pts. Redo operation were performed in 14 (2.1%)
pts after AVR in a reason of aneurysm forming.
Conclusion
Bicuspid aortic valve disease characterized by injury of
aortic valve and ascending aorta. Aneurysm forming
were observed in 380 (31.2%) patients with BAV, among
them in 39 (10.3%) with dissection. Redo operations in a
reason of aneurysm forming needs 2.1% in the elective
AVR group. Operative treatment of patients with BAV
permitted to obtain good and satisfactory remote results
in 84.4% and 10.9% cases.
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